{"url_path":"/sec/kura/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1422143/0001193125-26-257368-index.html","accession_number":"0001193125-26-257368","cik":"0001422143","ticker":"KURA","issuer_name":"Kura Oncology, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1422143/0001193125-26-257368-index.html","primary_entity_key":"0001422143","primary_entity_name":"Kura Oncology, Inc."},"word_count":107,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.\n\nDescription\n\n \n\n \n\n99.1\n\n[Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan and Forms of Option Agreement, Notice of Exercise and Stock Option Grant Notice thereunder.](kura-ex99_1.htm)\n\n \n\n \n\n \n\n99.2\n\n \n\n[Kura Oncology, Inc. Amended and Restated 2015 Employee Stock Purchase Plan.](kura-ex99_2.htm)\n\n \n\n \n\n \n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nKURA ONCOLOGY, INC.\n\nDate: June 4, 2026\n\nBy:\n\n/s/ Teresa Bair\n\nTeresa Bair\n\nChief Legal Officer"}